A 53-page read on the Pfizer vaccine, courtesy of FDA - ahead of Thursday’s meeting https://www.fda.gov/media/144245/download

2 deaths in the vaccine group: one participant with baseline obesity and pre-existing atherosclerosis died 3 days after Dose 1, and the other participant experienced cardiac arrest 62 days after 2nd vaccination

Overall: “Among participants with no evidence of COVID-19 prior to vaccination, the vaccine was effective in reducing the risk of COVID-19 and severe COVID-19 after Dose 1. Fewer severe cases were also observed.”

the vaccine works to halt sympt. Covid. But FDA says: “if efficacy against asymptomatic infection were lower than efficacy against symptomatic infection, asymptomatic cases in combin. with reduced mask-wearing and social distancing could result in signif. continued transmission.”

so many scare comments - to be clear, FDA says the vaccine shows "a favorable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA."